![](https://cannintelligence.com/wp-content/uploads/2023/11/handshake-22nd-century-380x228.jpg)
22nd Century sells its hemp/cannabis business to cut debt and operating costs
29th November 2023 - News analysis |
US-based 22nd Century will sell its hemp/cannabis subsidiary, GVB Biopharma, to an entity affiliated with current GVB employees and will use the sale proceeds to pay off debt and further deleverage its balance sheet